We are live on
!
Find out more
Aptevo Therapeutics
APVO
APVO
hedge funds and large institutions have $14.8M invested in Aptevo Therapeutics in 2019 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
58% more capital invested
Capital invested by funds: $9.35M → $14.8M (+$5.4M)
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$675K
Puts
–
Net Calls
+$675K
Net Calls Change
+$675K
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$370K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$128K |
| 3 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$101K |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
-$54K |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$12K |